Crinetics Pharmaceuticals
CRNX
CRNX
128 hedge funds and large institutions have $884M invested in Crinetics Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.3% more ownership
Funds ownership: 101.83% → 102.14% (+0.3%)
11% less capital invested
Capital invested by funds: $993M → $884M (-$109M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
128
Holding in Top 10
6
Calls
$472K
Puts
$2K
Top Buyers
| 1 | +$14.9M | |
| 2 | +$13.3M | |
| 3 | +$12.1M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$8.62M |
| 5 |
Morgan Stanley
New York
|
+$8.04M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$19.2M | |
| 3 | -$18.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.5M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$9.46M |